245 related articles for article (PubMed ID: 34688997)
21. Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance.
Du M; Thompson J; Fisher H; Zhang P; Huang CC; Wang L
Lung Cancer; 2018 Jun; 120():113-121. PubMed ID: 29748005
[TBL] [Abstract][Full Text] [Related]
22. Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer.
Nair VS; Hui AB; Chabon JJ; Esfahani MS; Stehr H; Nabet BY; Zhou L; Chaudhuri AA; Benson J; Ayers K; Bedi H; Ramsey M; Van Wert R; Antic S; Lui N; Backhus L; Berry M; Sung AW; Massion PP; Shrager JB; Alizadeh AA; Diehn M
Cancer Res; 2022 Aug; 82(16):2838-2847. PubMed ID: 35748739
[TBL] [Abstract][Full Text] [Related]
23. Plasma cell-free DNA 5-hydroxymethylcytosine and whole-genome sequencing signatures for early detection of esophageal cancer.
Lu D; Wu X; Wu W; Wu S; Li H; Zhang Y; Yan X; Zhai J; Dong X; Feng S; Zhang X; Sun F; Wang S; Cai K
Cell Death Dis; 2023 Dec; 14(12):843. PubMed ID: 38114477
[TBL] [Abstract][Full Text] [Related]
24. Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma.
Yan T; Cui H; Zhou Y; Yang B; Kong P; Zhang Y; Liu Y; Wang B; Cheng Y; Li J; Guo S; Xu E; Liu H; Cheng C; Zhang L; Chen L; Zhuang X; Qian Y; Yang J; Ma Y; Li H; Wang F; Liu J; Liu X; Su D; Wang Y; Sun R; Guo S; Li Y; Cheng X; Liu Z; Zhan Q; Cui Y
Nat Commun; 2019 Apr; 10(1):1670. PubMed ID: 30975989
[TBL] [Abstract][Full Text] [Related]
25. Genome-Wide DNA Methylation Profiling of Esophageal Squamous Cell Carcinoma from Global High-Incidence Regions Identifies Crucial Genes and Potential Cancer Markers.
Talukdar FR; Soares Lima SC; Khoueiry R; Laskar RS; Cuenin C; Sorroche BP; Boisson AC; Abedi-Ardekani B; Carreira C; Menya D; Dzamalala CP; Assefa M; Aseffa A; Miranda-Gonçalves V; Jerónimo C; Henrique RM; Shakeri R; Malekzadeh R; Gasmelseed N; Ellaithi M; Gangane N; Middleton DRS; Le Calvez-Kelm F; Ghantous A; Roux ML; Schüz J; McCormack V; Parker MI; Pinto LFR; Herceg Z
Cancer Res; 2021 May; 81(10):2612-2624. PubMed ID: 33741694
[TBL] [Abstract][Full Text] [Related]
26. Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma.
Coto-Llerena M; Benjak A; Gallon J; Meier MA; Boldanova T; Terracciano LM; Ng CKY; Piscuoglio S
JCO Precis Oncol; 2022 Mar; 6():e2100335. PubMed ID: 35263170
[TBL] [Abstract][Full Text] [Related]
27. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.
Zill OA; Banks KC; Fairclough SR; Mortimer SA; Vowles JV; Mokhtari R; Gandara DR; Mack PC; Odegaard JI; Nagy RJ; Baca AM; Eltoukhy H; Chudova DI; Lanman RB; Talasaz A
Clin Cancer Res; 2018 Aug; 24(15):3528-3538. PubMed ID: 29776953
[No Abstract] [Full Text] [Related]
28. Circulating Cell-Free DNA Levels Could Predict Oncological Outcomes of Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma.
Hsieh CC; Hsu HS; Chang SC; Chen YJ
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999323
[TBL] [Abstract][Full Text] [Related]
29. High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer.
Ashley CW; Selenica P; Patel J; Wu M; Nincevic J; Lakhman Y; Zhou Q; Shah RH; Berger MF; Da Cruz Paula A; Brown DN; Marra A; Iasonos A; Momeni-Boroujeni A; Alektiar KM; Long Roche K; Zivanovic O; Mueller JJ; Zamarin D; Broach VA; Sonoda Y; Leitao MM; Friedman CF; Jewell E; Reis-Filho JS; Ellenson LH; Aghajanian C; Abu-Rustum NR; Cadoo K; Weigelt B
Clin Cancer Res; 2023 Jan; 29(2):410-421. PubMed ID: 36007103
[TBL] [Abstract][Full Text] [Related]
30. [Development and validation of predictive models for esophageal squamous cell carcinoma and its precancerous lesions using terminal motif analysis in circulating cell-free DNA].
Liu SY; Li ZQ; Dou LZ; Zhang YM; Liu Y; Liu YM; Ke Y; Liu XD; Wu HR; Chu JT; He S; Wang GQ
Zhonghua Zhong Liu Za Zhi; 2024 Jun; 46(6):549-565. PubMed ID: 38880735
[No Abstract] [Full Text] [Related]
31. Identification of liquid biopsy-based mutations in colorectal cancer by targeted sequencing assays.
Szász I; Kiss T; Mokánszki A; Koroknai V; Deák J; Patel V; Jámbor K; Ádány R; Balázs M
Mol Cell Probes; 2023 Feb; 67():101888. PubMed ID: 36513244
[TBL] [Abstract][Full Text] [Related]
32. [High throughput-targeted sequencing panel for exploring radiosensitivity associated genes in esophageal squamous cell carcinoma].
Qiao Y; Hu CX; Song DA; Li SQ; Zhou LH; Jiang XD
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):584-588. PubMed ID: 28835080
[No Abstract] [Full Text] [Related]
33. Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.
Adalsteinsson VA; Ha G; Freeman SS; Choudhury AD; Stover DG; Parsons HA; Gydush G; Reed SC; Rotem D; Rhoades J; Loginov D; Livitz D; Rosebrock D; Leshchiner I; Kim J; Stewart C; Rosenberg M; Francis JM; Zhang CZ; Cohen O; Oh C; Ding H; Polak P; Lloyd M; Mahmud S; Helvie K; Merrill MS; Santiago RA; O'Connor EP; Jeong SH; Leeson R; Barry RM; Kramkowski JF; Zhang Z; Polacek L; Lohr JG; Schleicher M; Lipscomb E; Saltzman A; Oliver NM; Marini L; Waks AG; Harshman LC; Tolaney SM; Van Allen EM; Winer EP; Lin NU; Nakabayashi M; Taplin ME; Johannessen CM; Garraway LA; Golub TR; Boehm JS; Wagle N; Getz G; Love JC; Meyerson M
Nat Commun; 2017 Nov; 8(1):1324. PubMed ID: 29109393
[TBL] [Abstract][Full Text] [Related]
34. Novel candidate genes may be possible predisposing factors revealed by whole exome sequencing in familial esophageal squamous cell carcinoma.
Forouzanfar N; Baranova A; Milanizadeh S; Heravi-Moussavi A; Jebelli A; Abbaszadegan MR
Tumour Biol; 2017 May; 39(5):1010428317699115. PubMed ID: 28459198
[TBL] [Abstract][Full Text] [Related]
35. Genome Sequencing in Esophageal Squamous Cell Carcinoma.
Pillai S; Maksemous N; Lam AK
Methods Mol Biol; 2020; 2129():217-240. PubMed ID: 32056181
[TBL] [Abstract][Full Text] [Related]
36. Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells.
van 't Erve I; Medina JE; Leal A; Papp E; Phallen J; Adleff V; Chiao EJ; Arun AS; Bolhuis K; Simmons JK; Karandikar A; Valkenburg KC; Sausen M; Angiuoli SV; Scharpf RB; Punt CJA; Meijer GA; Velculescu VE; Fijneman RJA
Clin Cancer Res; 2023 Mar; 29(5):899-909. PubMed ID: 36534496
[TBL] [Abstract][Full Text] [Related]
37. Noninvasive diagnosis and monitoring of mutations by deep sequencing of circulating tumor DNA in esophageal squamous cell carcinoma.
Luo H; Li H; Hu Z; Wu H; Liu C; Li Y; Zhang X; Lin P; Hou Q; Ding G; Wang Y; Li S; Wei D; Qiu F; Li Y; Wu S
Biochem Biophys Res Commun; 2016 Mar; 471(4):596-602. PubMed ID: 26876573
[TBL] [Abstract][Full Text] [Related]
38. Genomic profiling of esophageal squamous cell carcinoma (ESCC)-Basis for precision medicine.
Yang JW; Choi YL
Pathol Res Pract; 2017 Jul; 213(7):836-841. PubMed ID: 28554745
[TBL] [Abstract][Full Text] [Related]
39. Variants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell-free DNA by next-generation sequencing.
Wang JF; Pu X; Zhang X; Chen K; Xi Y; Wang J; Mao X; Zhang J; Heymach JV; Antonoff MB; Hofstetter WL; Mehran RJ; Rice DC; Roth JA; Sepesi B; Swisher SG; Vaporciyan AA; Walsh GL; Meng QH; Shaw KR; Eterovic AK; Fang B
Cancer; 2018 Mar; 124(5):1061-1069. PubMed ID: 29178133
[TBL] [Abstract][Full Text] [Related]
40. Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamous cell carcinoma.
Min Q; Wang Y; Wu Q; Li X; Teng H; Fan J; Cao Y; Fan P; Zhan Q
JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34494553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
